|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-5-9
|
|
pubmed:abstractText |
To examine p53 and BCL2 expression in high-risk breast cancer patients randomized to postmastectomy radiotherapy (PMRT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1651-226X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
608-17
|
|
pubmed:dateRevised |
2009-5-12
|
|
pubmed:meshHeading |
pubmed-meshheading:18465329-Breast Neoplasms,
pubmed-meshheading:18465329-Combined Modality Therapy,
pubmed-meshheading:18465329-Female,
pubmed-meshheading:18465329-Humans,
pubmed-meshheading:18465329-Immunohistochemistry,
pubmed-meshheading:18465329-Microarray Analysis,
pubmed-meshheading:18465329-Prognosis,
pubmed-meshheading:18465329-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:18465329-Risk Factors,
pubmed-meshheading:18465329-Survival Rate,
pubmed-meshheading:18465329-Tumor Suppressor Protein p53
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.
|
|
pubmed:affiliation |
Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
